Sotera Health (SHC) Expected to Announce Earnings on Thursday

Sotera Health (NASDAQ:SHC) is expected to be releasing its earnings data before the market opens on Thursday, February 27th. Analysts expect Sotera Health to post earnings of $0.21 per share and revenue of $291.37 million for the quarter. Persons that wish to listen to the company’s earnings conference call can do so using this link.

Sotera Health Trading Up 1.9 %

Shares of SHC stock opened at $13.73 on Wednesday. Sotera Health has a twelve month low of $10.71 and a twelve month high of $17.44. The stock’s fifty day simple moving average is $13.48 and its 200 day simple moving average is $14.54. The company has a quick ratio of 2.61, a current ratio of 2.88 and a debt-to-equity ratio of 4.91. The firm has a market capitalization of $3.89 billion, a P/E ratio of 54.92 and a beta of 1.91.

Wall Street Analyst Weigh In

SHC has been the topic of several research reports. Citigroup boosted their price target on Sotera Health from $18.00 to $20.00 and gave the stock a “buy” rating in a report on Wednesday, November 6th. The Goldman Sachs Group began coverage on shares of Sotera Health in a report on Friday, December 6th. They set a “neutral” rating and a $14.00 target price on the stock. Royal Bank of Canada reaffirmed an “outperform” rating and set a $17.00 price target on shares of Sotera Health in a research note on Thursday, November 21st. Finally, Barclays cut their price target on shares of Sotera Health from $18.00 to $17.00 and set an “overweight” rating on the stock in a report on Tuesday, February 18th. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $16.08.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.